BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29875233)

  • 21. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL
    Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
    Solana-Altabella A; Valero S; Balaguer J; Escobar-Cava P; Barranco H; López E; Ribes-Artero H; Poveda JL
    J Oncol Pharm Pract; 2020 Dec; 26(8):1829-1835. PubMed ID: 32063104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal Lower-Dose (20 µg) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds.
    Tuncer S; Balcı Ö; Tanyıldız B; Kebudi R; Shields CL
    Ophthalmic Surg Lasers Imaging Retina; 2015 Oct; 46(9):942-8. PubMed ID: 26469234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model.
    Kaczmarek JV; Bogan CM; Pierce JM; Tao YK; Chen SC; Liu Q; Liu X; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Friedman DL; Richmond A; Daniels AB
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):8. PubMed ID: 34757417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
    Kiratli H; Koç İ; Varan A; Akyüz C
    Eur J Ophthalmol; 2017 Jun; 27(4):423-427. PubMed ID: 28106239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma.
    Hsieh T; Liao A; Francis JH; Lavery JA; Mauguen A; Brodie SE; Abramson DH
    PLoS One; 2020; 15(7):e0235016. PubMed ID: 32609726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal injection of melphalan for intraocular retinoblastoma.
    Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A
    Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
    Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
    Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.
    Venturi C; Bracco S; Cerase A; Cioni S; Galluzzi P; Gennari P; Vallone IM; Tinturini R; Vittori C; De Francesco S; Caini M; D'Ambrosio A; Toti P; Renieri A; Hadjistilianou T
    Acta Ophthalmol; 2013 Jun; 91(4):335-42. PubMed ID: 22268993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.
    Riazi-Esfahani H; Masoomian B; Khodabandeh A; Amini A; Taghizadeh S; Boujabadi L; Sharifkashani S; Shields CL; Ghassemi F
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1167-1175. PubMed ID: 36401651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function.
    Abdelhakim AH; Francis JH; Marr BP; Gobin YP; Abramson DH; Brodie SE
    Br J Ophthalmol; 2017 May; 101(5):623-628. PubMed ID: 27539090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.
    Francis JH; Roosipu N; Levin AM; Brodie SE; Dunkel IJ; Gobin YP; Abramson DH
    Neoplasia; 2018 Aug; 20(8):757-763. PubMed ID: 29940303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.
    Bogan CM; Kaczmarek JV; Pierce JM; Chen SC; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Nadelmann JB; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
    Br J Ophthalmol; 2022 Feb; 106(2):288-296. PubMed ID: 33972235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results.
    Abramson DH; Marr BP; Dunkel IJ; Brodie S; Zabor EC; Driscoll SJ; Gobin YP
    Br J Ophthalmol; 2012 Apr; 96(4):499-502. PubMed ID: 22053101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.